A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy-Reference-Cited by-同舟云学术

A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy

Published:2013-03-29 Issue:7 Volume:30 Page:846-854
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Derosa G.¹,Cicero A. F. G.²,Franzetti I. G.³,Querci F.⁴,Carbone A.⁵,Piccinni M. N.⁶,D'Angelo A.¹,Fogari E.¹,Maffioli P.¹

Affiliation:

1. Department of Internal Medicine and Therapeutics; University of Pavia; Pavia

2. Aging and Kidney diseases; ‘G. Descovich’ Atherosclerosis Study Center; University of Bologna; Bologna

3. Metabolic Unit; Regional Hospital; Varese

4. Ospedale Pesenti Fenaroli; Alzano Lombardo; Bergamo; Italy

5. Hospital Center of Diabetes; Sant'Angelo Lodigiano; Lodi; Italy

6. Ospedale della Carità; Casalbuttano; Cremona; Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.12158/fullpdf

Reference30 articles.

1. Lilly Lecture 1987. The triumvirate: β-cell, muscle, liver. A collision responsible for NIDDM;DeFronzo;Diabetes,1988

2. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus;Weyer;J Clin Invest,1999

3. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis;PLOS ONE;2020-07-24

2. Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy;Diabetes Research and Clinical Practice;2017-09

3. Pharmacotherapy of ‘treatment resistant’ type 2 diabetes;Expert Opinion on Pharmacotherapy;2017-03

4. Triple therapy combinations for the treatment of type 2 diabetes – A network meta-analysis;Diabetes Research and Clinical Practice;2016-06

5. Triple therapy in type 2 diabetes; a systematic review and network meta-analysis;PeerJ;2015-12-07